These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 34103005)

  • 1. The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
    Vizirianakis IS; Chatzopoulou F; Papazoglou AS; Karagiannidis E; Sofidis G; Stalikas N; Stefopoulos C; Kyritsis KA; Mittas N; Theodoroula NF; Lampri A; Mezarli E; Kartas A; Chatzidimitriou D; Papa-Konidari A; Angelis E; Karvounis Η; Sianos G
    BMC Cardiovasc Disord; 2021 Jun; 21(1):284. PubMed ID: 34103005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
    Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".
    Moysidis DV; Daios S; Anastasiou V; Liatsos AC; Papazoglou AS; Karagiannidis E; Kamperidis V; Makedou K; Thisiadou A; Karalazou P; Papadakis M; Savopoulos C; Ziakas A; Giannakoulas G; Vassilikos V; Giannopoulos G
    BMC Cardiovasc Disord; 2023 Mar; 23(1):149. PubMed ID: 36959584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial.
    Mittas N; Chatzopoulou F; Kyritsis KA; Papagiannopoulos CI; Theodoroula NF; Papazoglou AS; Karagiannidis E; Sofidis G; Moysidis DV; Stalikas N; Papa A; Chatzidimitriou D; Sianos G; Angelis L; Vizirianakis IS
    Front Cardiovasc Med; 2021; 8():812182. PubMed ID: 35118145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial.
    Andreini D; Modolo R; Katagiri Y; Mushtaq S; Sonck J; Collet C; De Martini S; Roberto M; Tanaka K; Miyazaki Y; Czapla J; Schoors D; Plass A; Maisano F; Kaufmann P; Orry X; Metzdorf PA; Folliguet T; Färber G; Diamantis I; Schönweiß M; Bonalumi G; Guglielmo M; Ferrari C; Olivares P; Cavallotti L; Leal I; Lindeboom W; Onuma Y; Serruys PW; Bartorelli AL;
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e007607. PubMed ID: 31833413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
    Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
    Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial.
    Chen IC; Lee CH; Chao TH; Tseng WK; Lin TH; Chung WJ; Li JK; Huang HL; Liu PY; Chao TK; Chu CY; Lin CC; Hsu PC; Lee WH; Lee PT; Li YH; Tseng SY; Tsai LM; Hwang JJ
    Trials; 2016 Feb; 17(1):112. PubMed ID: 26927298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Coronary Artery Disease.
    McPherson R; Tybjaerg-Hansen A
    Circ Res; 2016 Feb; 118(4):564-78. PubMed ID: 26892958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of coronary risk scoring systems to predict the severity of coronary artery disease using the SYNTAX score.
    Tolunay H; Kurmus O
    Cardiol J; 2016; 23(1):51-6. PubMed ID: 26503075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
    Farooq V; Girasis C; Magro M; Onuma Y; Morel MA; Heo JH; Garcia-Garcia H; Kappetein AP; van den Brand M; Holmes DR; Mack M; Feldman T; Colombo A; Ståhle E; James S; Carrié D; Fournial G; van Es GA; Dawkins KD; Mohr FW; Morice MC; Serruys PW
    EuroIntervention; 2013 Mar; 8(11):1277-85. PubMed ID: 23537954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
    Takahashi K; Serruys PW; Fuster V; Farkouh ME; Spertus JA; Cohen DJ; Park SJ; Park DW; Ahn JM; Kappetein AP; Head SJ; Thuijs DJ; Onuma Y; Kent DM; Steyerberg EW; van Klaveren D;
    Lancet; 2020 Oct; 396(10260):1399-1412. PubMed ID: 33038944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of coronary artery disease severity in lower extremity artery disease patients: A correlation study of TASC II classification, Syntax and Syntax II scores.
    Vuruskan E; Saracoglu E; Polat M; Duzen IV
    Cardiol J; 2017; 24(5):495-501. PubMed ID: 28353312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.
    Weijmans M; de Bakker PI; van der Graaf Y; Asselbergs FW; Algra A; Jan de Borst G; Spiering W; Visseren FL;
    Atherosclerosis; 2015 Apr; 239(2):451-8. PubMed ID: 25687271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy.
    Xu B; Bettinger N; Guan C; Redfors B; Yang Y; Li B; Han Y; Su X; Yuan Z; Généreux P
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):541-548. PubMed ID: 28109056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting long-term ischemic events using routine clinical parameters in patients with coronary artery disease: The OPT-CAD risk score.
    Han Y; Chen J; Qiu M; Li Y; Li J; Feng Y; Qiu J; Meng L; Sun Y; Tao G; Wu Z; Yang C; Guo J; Pu K; Chen S; Wang X
    Cardiovasc Ther; 2018 Oct; 36(5):e12441. PubMed ID: 29869835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Quantitative Flow Ratio Based Functional SYNTAX Score in Patients With Left Main or Multivessel Coronary Artery Disease.
    Zhang R; Song C; Guan C; Liu Q; Wang C; Xie L; Sun Z; Cai M; Zhang M; Wang H; Liu J; Dou K; Xu B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009155. PubMed ID: 33040580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of coronary artery stenosis and atherosclerotic plaque burden assessment for predicting 30-day revascularization and 2-year major adverse cardiac events.
    Kishi S; Magalhães TA; Cerci RJ; Zimmermann E; Matheson MB; Vavere A; Tanami Y; Kitslaar PH; George RT; Brinker J; Miller JM; Clouse ME; Lemos PA; Niinuma H; Reiber JHC; Kofoed KF; Rochitte CE; Rybicki FJ; Di Carli MF; Cox C; Lima JAC; Arbab-Zadeh A
    Int J Cardiovasc Imaging; 2020 Dec; 36(12):2365-2375. PubMed ID: 32361925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.